NextCure, Inc.
USD5.11
-0.29 (-5.37%)
CEO
Michael S. Richman
IPO Date
2019-05-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.32
Prev. Close
$5.40
Day Low
$4.81
Day High
$5.65
52W Low
$1.55
52W High
$15.74
Market Cap
$0.01B
Volume
0.69M
| 2,340 |
| $2.02 |
| 22 Jun 2026 | Feigal Ellen | director | A-Award | Acquired | 2,340 | $2.02 |
| 22 Jun 2026 | Jones Elaine V | director | A-Award | Acquired | 2,340 | $2.02 |
| 22 Jun 2026 | Borgman Anne Elizabeth | director | A-Award | Acquired | 2,340 | $2.02 |
| 22 Jun 2026 | Webster Stephen W | director | A-Award | Acquired | 2,340 | $2.02 |
| 3 Feb 2026 | Shaw Kevin G. | Sr VP, General Counsel | A-Award | Acquired | 8,270 | $10.85 |
| 3 Feb 2026 | Guha Udayan | Chief Medical Officer | A-Award | Acquired | 14,670 | $10.85 |
| 3 Feb 2026 | Kundu Sourav | Sr VP, Dev. & Mfg. | A-Award | Acquired | 8,270 | $10.85 |
| 3 Feb 2026 | Mayer Timothy | Chief Operating Officer | A-Award | Acquired | 14,670 | $10.85 |